Gastrin-releasing peptide: a potential growth factor expressed in human neuroblastoma tumors

This publication has 10 references indexed in Scilit:

• Effect of prostatic neuropeptides on invasion and migration of PC-3 prostate cancer cells
  Cancer Letters, 1998
• Bombesin/gastrin-releasing peptide antagonists RC-3095 and RC-3940-II inhibit tumor growth and decrease the levels and mRNA expression of epidermal growth factor receptors in H-69 small cell lung carcinoma
  Cancer, 1998
• Inhibition of growth of MDA-MB-231 human breast cancer xenografts in nude mice by bombesin/gastrin-releasing peptide (GRP) antagonists RC-3940-II and RC-3095
  European Journal Of Cancer, 1998
• Luteinizing hormone-releasing hormone antagonist Cetrorelix (SB-75) and bombesin antagonist RC-3940-II inhibit the growth of androgen-independent PC-3 prostate cancer in nude mice
  The Prostate, 1997
• Antitumor Activity of a Monoclonal Antibody Directed Against Gastrin-Releasing Peptide in Patients With Small Cell Lung Cancer
  Chest, 1997
• Bombesin stimulates growth of human prostatic cancer cellsin vitro
  Cancer, 1990
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
  Analytical Biochemistry, 1987
• Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer
  Nature, 1985
• Gastrin releasing peptide is a selective mitogen for small cell lung carcinoma in vitro.
  Journal of Clinical Investigation, 1985
• Bombesin stimulation of DNA synthesis and cell division in cultures of Swiss 3T3 cells.
  Proceedings of the National Academy of Sciences, 1983